A comprehensive view of Pfizer Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer Applies for Patent on Imidazo[4,5-C]Pyridine Derivatives as Toll-Like Receptor Agonsits
Published: April 18, 2024 by Pharmaceutical Patent News
Pfizer Applies for Patent on Recombinant Expression of Klebsiella Pneumoniae O-Antigens in Escherichia Coli
Published: April 17, 2024 by Biotechnology Patent News
US Patent Issued to Pfizer, The Regents of the University of California on April 16 for "Anti-CXCR5 antibodies and compositions and uses thereof" (California Inventors)
Published: April 17, 2024 by U.S. Fed News
Pfizer and BioNTech get temporary reprieve in patent dispute with Moderna, allowing more time for the Patent Trial and Appeal Board to review challenges; Pfizer and BioNTech’s COVID-19 vaccine to remain on the market despite lawsuit
Published: April 15, 2024 by FiercePharma
Pfizer Seeks Patent for CDK4 Inhibitor for the Treatment of Cancer
Published: April 15, 2024 by Pharmaceutical Patent News

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count